Clinical Trial Update: Docetaxel and Ifosfamide in Treating Women With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of docetaxel and ifosfamide in women with metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Ifex (ifosfamide)
• Taxotere (docetaxel)

Snippet

Sponsor: Grupo Oncologico Cooperativo del Sur | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN